s6y ADARx Pharmaceuticals, Inc. EFFECT

ADARx Pharmaceuticals, Inc. EFFECT, filed Sep 24, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 24, 2026 4:00 P.M.
Form: S-1
CIK: 0001802369
Company Name: ADARx Pharmaceuticals, Inc.
File Number: 333-298782